Secretome Therapeutics Employee Directory
Biotechnology ResearchMaryland, United States11-50 Employees
Secretome Therapeutics is a clinical-stage biotechnology company focused on developing cellular therapies for orphan and underserved cardiac diseases. Its lead candidate, STM-01, uses neonatal cardiac progenitor cells isolated from tissue removed during life-saving open-heart surgery on newborns with congenital heart defects. The main targeted indication is Duchenne muscular dystrophy-associated cardiomyopathy, and the program also encompasses inflammatory cardiovascular conditions within its development scope. Based in Baltimore, Maryland, the company operates in the biotechnology research sector and maintains a relatively small team. In May 2026, David Lubner joined Secretome Therapeutics' Board of Directors, marking a governance development for the company.